Fleetyr | $750,000 | (Sep 25, 2025)
enaDyne | $8,220,207 | (Sep 25, 2025)
OnFinance AI | $4,200,000 | (Sep 25, 2025)
Certified by Founder
Lodge
OncoPep, Inc.
start up
United States
- Boston, Massachusetts
- 09/12/2021
- Series D
- $11,000,000
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell focused technologies are designed to be used on their own or in combination with other immunotherapeutics.
- Industry Biotechnology Research
- Website https://oncopep.com/
- LinkedIn https://www.linkedin.com/company/oncopep-inc./
AmplifyMD | $20,000,000 | (Sep 25, 2025)
amplio | $11,100,000 | (Sep 25, 2025)
Synthesized | $20,000,000 | (Sep 25, 2025)
FYR Bio | $8,000,000 | (Sep 25, 2025)
yasp | $5,000,000 | (Sep 25, 2025)
BizzyCar | $20,000,000 | (Sep 25, 2025)
Emergent | $23,000,000 | (Sep 25, 2025)
Lifeguard | $1,300,000 | (Sep 25, 2025)
Sparrow Pharmaceuticals, Inc. | $95,000,000 | (Sep 25, 2025)